Trial Profile
Multicentre, Randomized, Double-blind, Parallel Group, Placebo-Controlled Study on the Therapeutic Efficacy and Safety of Beclomethasone Dipropionate Suspension for Inhalation 800 microg Twice Daily vs. Placebo Added to Antibiotic Therapy in Patients With Acute Rhinosinusitis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Beclometasone (Primary)
- Indications Rhinosinusitis
- Focus Therapeutic Use
- Acronyms CLEAR
- Sponsors Chiesi Farmaceutici
- 17 May 2014 Status changed from active, no longer recruiting to completed European Clinical Trials Database.
- 14 Feb 2014 Planned End Date changed from 1 Dec 2013 to 1 Feb 2014 as reported by ClinicalTrials.gov.
- 14 Feb 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.